VJHemOnc is committed to improving our service to you

COSTEM 2019 | Can CAR-T cells replace ASCT in DLBCL?

VJHemOnc is committed to improving our service to you

Michael Bishop

Michael Bishop, MD, University of Chicago Medical Center, Chicago, IL, discusses the possibility of CAR-T cells in replacing autologous stem cell transplantation (ASCT) in diffuse large B-cell lymphoma (DLBCL). This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter